Chronic myeloid leukemia: cytogenetics and molecular biology’s part in the comprehension and management of the pathology and treatment evolution

被引：0
|
作者：
Sara Benchikh
Amale Bousfiha
Adil El Hamouchi
Somda Georgina Charlene Soro
Abderrahim Malki
Sanaa Nassereddine
机构：
[1] Pasteur Institute of Morocco,Laboratory of Cytogenetics
[2] Hassan II University,Laboratory of Physiopathology and Molecular Genetics, Faculty of Sciences Ben M’Sik
来源：
Egyptian Journal of Medical Human Genetics | / 23卷
关键词：
CML; Tyrosine kinase; Cytogenetic; Molecular biology; Treatment resistance; Treatment response;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Management Challenges in Patients with Treatment-Free Remission of Chronic Myeloid Leukemia
    Musteata, Vasile
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S374 - S374
  • [42] Management of Chronic Myeloid Leukemia Patients Resistant to Tyrosine Kinase Inhibitors Treatment
    Wieczorek, Agnieszka
    Uharek, Lutz
    BIOMARKER INSIGHTS, 2015, 10 : 49 - 54
  • [43] COEXISTENCE OF CHRONIC MYELOID LEUKEMIA AND WALDENSTROM MACROGLOBULINEMIA: MANAGEMENT AND TREATMENT ABOUT A CASE
    Francisco Daniel, Munoz Lopez
    Raya Maria, Perez
    Maria Magdalena, Alcala Pena
    Marquez Alberto, Doblas
    Ana Maria, Mena Santana
    HAEMATOLOGICA, 2021, 106 (10) : 384 - 384
  • [44] RECENT ADVANCES IN MOLECULAR-BIOLOGY OF CHRONIC MYELOID-LEUKEMIA - IS THE PATHOGENETIC PUZZLE APPROACHING SOLUTION
    GOLDMAN, JM
    BONE MARROW TRANSPLANTATION, 1989, 4 : 129 - 130
  • [45] Molecular genetics and management of world health organization defined atypical chronic myeloid leukemia
    Yingxin Sun
    Qinrong Wang
    Xingxia Zhang
    Zhiyu Zhang
    Qian Wang
    Jiannong Cen
    Mingqing Zhu
    Jinlan Pan
    Dandan Liu
    Depei Wu
    Yifeng Cai
    Suning Chen
    Annals of Hematology, 2023, 102 : 777 - 785
  • [46] Molecular genetics and management of world health organization defined atypical chronic myeloid leukemia
    Sun, Yingxin
    Wang, Qinrong
    Zhang, Xingxia
    Zhang, Zhiyu
    Wang, Qian
    Cen, Jiannong
    Zhu, Mingqing
    Pan, Jinlan
    Liu, Dandan
    Wu, Depei
    Cai, Yifeng
    Chen, Suning
    ANNALS OF HEMATOLOGY, 2023, 102 (04) : 777 - 785
  • [47] Cytogenetic clonal evolution in chronic myeloid leukemia during imatinib mesylate treatment.
    Klamova, H
    Brezinova, J
    Michalova, K
    Zemanova, Z
    Trneny, M
    BLOOD, 2005, 106 (11) : 291B - 291B
  • [48] Value of molecular monitoring during the treatment of chronic myeloid leukemia: A Cancer and Leukemia Group B study
    Stock, W
    Westbrook, CA
    Peterson, B
    Arthur, DC
    Szatrowski, TP
    Silver, RT
    Sher, DA
    Wu, D
    LeBeau, MM
    Schiffer, CA
    Bloomfield, CD
    JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (01) : 26 - 36
  • [49] EVOLUTION OF THE TREATMENT WITH TYROSINE KINASE INHIBITORS IN CHRONIC MYELOID LEUKEMIA: LINES OF TREATMENT, TOXICITY, DISCONTINUATION AND SURVIVAL
    Sanchez Pina, J. M.
    Rodriguez Rodriguez, M.
    Gonzalez Medina, J.
    Jimenez Ubieto, A.
    Ayala Diaz, R.
    Gonzalez Arias, E.
    Redondo, S.
    Osorio Prendes, S.
    Foncillas Garcia, M. A.
    Garcia Gutierrez, V
    Martinez Lopez, J.
    HAEMATOLOGICA, 2017, 102 : 283 - 283
  • [50] Mechanism of salidroside in the treatment of chronic myeloid leukemia based on the network pharmacology and molecular docking
    Chai, Yihong
    Chen, Feng
    Li, Zijian
    Yang, Panpan
    Zhou, Qi
    Liu, Wenling
    Xi, Yaming
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2023, 25 (02): : 384 - 395
12345